VXRT - What's Going On With Vaxart (VXRT) Stock? | Benzinga
Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 17.8% to $0.66 Tuesday morning amid a number of recent news items. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services with the total contract value of $9,271,193.
This entails funding for clinical trial planning activities related to a Phase 2b trial comparing Vaxart’s XBB vaccine candidate with an mRNA comparator, focusing on efficacy for symptomatic ...
VXRT) Stock?>Full story available on Benzinga.com